Regulation of heart function by endogenous gaseous mediators-crosstalk between nitric oxide and hydrogen sulfide

Antioxidants and Redox Signaling

Volumn 14, Issue 11, 2011, Pages 2081-2091

  Yong, Qian Chen ^a   Cheong, Jia Ling ^a   Hua, Fei ^a   Deng, Lih Wen ^a   Khoo, Yok Moi ^a   Lee, How Sung ^a   Perry, Alexis ^b   Wood, Mark ^b   Whiteman, Matthew ^b   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ARGININE; CALCIUM; CYSTEINE; GLUTATHIONE; HYDROGEN SULFIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; CAFFEINE; CALCIUM SIGNALING; CARDIOTONIC AGENTS; CELLS, CULTURED; DEPRESSION, CHEMICAL; ELECTRIC STIMULATION; GASES; HEART; HYDROGEN SULFIDE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79956098293     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3572     Document Type: Article

References (50)

1. Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, and Moore PK. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 149: 625-634, 2006. (Pubitemid 44748055)
2. Bers D. Calcium fluxes involved in control of cardiac myo-cyte contraction. Circ Res 87: 275-281, 2000. (Pubitemid 30655967)
3. Bridge J, Smolley J, and Spitzer K. The relationship between charge movements associated with ICa and INa-Ca in car-diac myocytes. Science 248: 376-378, 1990.
4. Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, and Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic in-tervention in neurodegenerative disorders. Antioxid Redox Signal 13: 1763-1811, 2010.
5. Cooper LT Jr. Myocarditis. N Engl J Med 360:1526-1538,2009.
6. Dedkova EN, Ji X, Wang YG, Blatter LA, and Lipsius SL. Signaling mechanisms that mediate nitric oxide production induced by acetylcholine exposure and withdrawal in cat atrial myocytes. Circ Res 93: 1233-1240, 2003. (Pubitemid 37543064)
7. Dombkowski R, Russell M, Schulman A, Doellman M, and Olson K. Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 288: R243-R252, 2005. (Pubitemid 40023936)
8. Ellis A, Li CG, and Rand MJ. Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta. Br J Pharmacol 129: 315-322, 2000. (Pubitemid 30072652)
9. Elsey DJ, Fowkes RC, and Baxter GF. L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther 15: 53-59, 2010.
10. Flesch M, Kilter H, Cremers B, Lenz O, Sudkamp M, Kuhn-Regnier F, and Bohm M. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther 281: 1340-1349, 1997. (Pubitemid 27258394)
11. Flores-Santana W, Switzer C, Ridnour L, Basudhar D, Mancardi D, Donzelli S, Thomas D, Miranda K, Fukuto J, and Wink D. Comparing the chemical biology of NO and HNO. Arch Pharm Res 32: 1139-1153, 2009.
12. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, and Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318: 756-763, 2004. (Pubitemid 38624219)
13. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, and Tang C. H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 313: 362-368, 2004. (Pubitemid 37543594)
14. Guo J, Murohara T, Buerke M, Scalia R, and Lefer A. Direct measurement of nitric oxide release from vascular endo-thelial cells. J Appl Physiol 81: 774-779, 1996. (Pubitemid 26303230)
15. Hall C and Garthwaite J. What is the real physiological NO concentration in vivo? Nitric Oxide 21: 92-103, 2009.
16. Hosoki R, Matsuki N, and Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531, 1997. (Pubitemid 27434718)
17. Huang S, Chua JH, Yew WS, Sivaraman J, Moore PK, Tan CH, and Deng LW. Site-directed mutagenesis on human cystathionine-gamma-lyase reveals insights into the modu-lation of H2S production. J Mol Biol 396: 708-718, 2010.
18. Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, and Kemp-Harper BK. Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci 29: 601-608, 2008.
19. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, and Bloch KD. Cardi-omyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces com-pensatory hypertrophy after myocardial infarction. Circ Res 94: 1256-1262, 2004. (Pubitemid 38656413)
20. Jeong S, Pae H, Oh G, Jeong G, Lee B, Lee S, Kim dY, Rhew H, Lee K, and Chung H. Hydrogen sulfide potentiates in-terleukin-1beta-induced nitric oxide production via en-hancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 345: 938-944, 2006. (Pubitemid 43776485)
21. Jones SP, Greer JJ, van Haperen R, Duncker DJ, de Crom R, and Lefer DJ. Endothelial nitric oxide synthase over-expression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA 100: 4891-4896, 2003. (Pubitemid 36457824)
22. Julian D, Statile J, Roepke TA, and Arp AJ. Sodium ni-troprusside potentiates hydrogen-sulfide-induced contrac-tions in body wall muscle from a marine worm. Biol Bull 209: 6-10, 2005. (Pubitemid 41192728)
23. Kaye DM, Wiviott SD, Balligand JL, Simmons WW, Smith TW, and Kelly RA. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of con-tractile function in adult rat ventricular myocytes. Circ Res 78: 217-224, 1996. (Pubitemid 26040851)
24. Kimura Y, Goto Y, and Kimura H. Hydrogen sulfide in-creases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 12: 1-13, 2010.
25. Kojda G, Kottenberg K, Nix P, Schluter KD, Piper HM, and Noack E. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78: 91-101, 1996. (Pubitemid 26004125)
26. Kojima H, Nakatsubo N Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diamino-fluoresceins. Anal Chem 70: 2446-2453, 1998.
27. Li L, Hsu A, Moore PK. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the car-diovascular system and in inflammation\a tale of three gases! Pharmacol Ther 123: 386-400, 2009.
28. Li L, Salto-Tellez M, Tan CH, Whiteman M, and Moore PK. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med 47: 103-113, 2009.
29. Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, and Moore PK. Characterization of a novel, water-soluble hydrogen sulfide-releasing mole-cule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117: 2351-2360, 2008. (Pubitemid 351653553)
30. Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, and Pagliaro P. Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Bio-phys Acta 1787: 864-872, 2009.
31. Massion PB, Feron O, Dessy C, and Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93: 388-398, 2003. (Pubitemid 37100003)
32. Pan T, Neo K, Hu L, Yong Q, and Bian J. H2S pre-conditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am J Physiol Cell Physiol 294: C169-C177, 2008.
33. Pan TT, Feng ZN, Lee SW, Moore PK, and Bian JS. En-dogenous hydrogen sulfide contributes to the cardioprotec-tion by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 40: 119-130, 2006. (Pubitemid 43012123)
34. Paolocci N and Wink D. The shy Angeli and his elusive creature: the HNO route to vasodilation. Am J Physiol Heart Circ Physiol 296: H1217-H1220, 2009.
35. Sham J, Hatem S, and Morad M. Species differences in the activity of the Na(+)-Ca2+ exchanger in mammalian car-diac myocytes. J Physiol 488 (Pt 3): 623-631, 1995.
36. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, and Kimura H. 3-Mercaptopyruvate sulfurtransfer-ase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11: 703-714, 2009.
37. Sun YG, Cao YX, Wang WW, Ma SF, Yao T, and Zhu YC. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 79: 632-641, 2008.
38. Tocchetti CG, Wang W, Froehlich JP, Huke S, Aon MA, Wilson GM, Di Benedetto G, O'Rourke B, Gao WD, Wink DA, Toscano JP, Zaccolo M, Bers DM, Valdivia HH, Cheng H, Kass DA, and Paolocci N. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res 100: 96-104, 2007. (Pubitemid 46066777)
39. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? Faseb J 16: 1792-1798, 2002. (Pubitemid 35340360)
40. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5: 493-501, 2003. (Pubitemid 37087410)
41. Wang R. Hydrogen sulfide: a new EDRF. Kidney Int 76: 700-704, 2009.
42. Wang X, Wang Q, Guo W, and Zhu YZ. Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart fail-ure: a mechanism through cardiac mitochondrial protection Biosci Rep 31: 87-98, 2010.
43. Webb A, Bond R, McLean P, Uppal R, Benjamin N, and Ahluwalia A. Reduction of nitrite to nitric oxide during is-chemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA 101: 13683-13688, 2004. (Pubitemid 39238463)
44. Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, and Moore PK. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sul-phide. Biochem Biophys Res Commun 343: 303-310, 2006.
45. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, and Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory me-diators in macrophages. Antioxid Redox Signal 12: 1147-1154, 2010.
46. Whiteman M and Moore PK. Hydrogen sulfide and the vas-culature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med 13: 488-507, 2009.
47. Yong QC, Lee SW, Foo CS, Neo KL, Chen X, and Bian JS. Endogenous hydrogen sulphide mediates the cardioprotec-tion induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol 295: H1330-H1340, 2008.
48. Yong QC, Pan TT, Hu LF, and Bian JS. Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts. J Mol Cell Cardiol 44: 701-710, 2008.
49. Zhao W, Zhang J, Lu Y, and Wang R The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. Embo J 20: 6008-6016, 2001. (Pubitemid 33049276)
50. Zhong G, Chen F, Cheng Y, Tang C, and Du J. The role of hydrogen sulfide generation in the pathogenesis of hyperhypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21: 1879-1885, 2003. (Pubitemid 37290106)